Michael Amoroso - 24 Oct 2022 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role
President and CEO, Director
Signature
/s/ Dario Scimeca, Attorney-in-fact for Michael Amoroso
Issuer symbol
DTIL
Transactions as of
24 Oct 2022
Net transactions value
$0
Form type
4
Filing time
26 Oct 2022, 07:00:09 UTC
Previous filing
18 Oct 2022
Next filing
04 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DTIL Stock Option (Right to Buy) Award $0 +250,000 $0.000000 250,000 24 Oct 2022 Common Stock 250,000 $1.38 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted stock options in accordance with the Reporting Person's employment agreement with the Issuer.
F2 The option vests as to 25% of the underlying shares on October 15, 2023 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.